Navigation Links
Need for federal protection against genetic discrimination
Date:3/24/2008

Washington A policy monograph highlighting the need for federal protections against genetic discrimination in employment and insurance practices was released today by the American College of Physicians (ACP). The six policy positions ACP believes should be included in the federal protections are the focus of the policy paper. http://www.acponline.org/advocacy/where_we_stand/policy/index.html.

While theyre not quite there, Congress does continue to move closer to passing federal legislation that protects the use of genetic information in employment and insurance coverage decisions, noted David C. Dale, MD, FACP president of the 125,000 member ACP. This monograph is important for the ongoing discussion.

ACPs first two positions consider insurance providers:

Position 1: Insurance providers should be prohibited from using an individuals genetic information to deny or limit health coverage or establish eligibility, enrollment, or premium contribution requirements.

Position 2: Insurance providers should be prohibited from establishing differential premiums based on an individuals genetic information or request for genetic screening.

ACPs policy positions result from a March 2007 survey conducted by the John Hopkins Genetics and Public Policy Center. It found that 86 percent of patients trust their physicians and 66 percent of patients trust genetic researchers with access to their genetic information. However, most people do not trust health insurers and employers not to misuse their genetic information through disclosure or discriminatory practices- should they have access to it.

The Colleges third position says:

Position 3: Employers should be prohibited from using an individuals genetic information in employment decisions, such as hiring, promoting, or terminating an employee or establishing the terms, conditions, and benefits or employment.

The ACP research looked at a report done by the National Partnership for Women and Families on behalf of the Coalition for Genetic Fairness that documents how fears of genetic discrimination negatively impact patient health care and financial well-being, public health, and scientific advancements. Examples include shielding genetic information from health care providers, refusing genetic testing, or undergoing testing using an alias.

Two more ACP positions which consider insurers and employers are:

Position 4: Insurers and employers should be prohibited from requiring individuals and families to undergo genetic testing

Position 5: Insurers and employers should be prohibited from collecting and/or disclosing an individual or familys genetic information. Written and informed consent should be required for each disclosure of genetic information and should include to whom the disclosure is made.

Finally, ACP considered specific Congressional considerations:

Position 6: Congress should establish comprehensive and uniform federal protection against genetic discrimination that closes the gaps in protection due to varying state laws. Federal protection should also cover ERISA health plans.


'/>"/>

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians
Source:Eurekalert

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. 2 federal public health grants awarded to Weill Cornell Medical College
4. $13 million federal grant for research into vascular disease awarded to Weill Cornell
5. HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System
6. Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System
7. Rain forest protection works in Peru
8. Antioxidants could provide all-purpose radiation protection
9. Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution
10. Better protection for biomedial devices could result from Rutgers-Camden research
11. A search for protection against chemotherapy cardiotoxicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first day ... announced plans to develop a first of its kind ... of IBM Watson. In the first application of ... (NYSE: IBM ), and Welltok will create a ... assessments with cognitive analytics, delivered on Welltok,s health optimization ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... Inc. (NYSE: BIOA ), a leader in renewable ... Ltd., its partner in the Sarnia ... CDN$25 million in the joint venture for 10% of ...  Mitsui will also play a stronger role in the ... , providing dedicated resources alongside BioAmber,s commercial team. ...
(Date:2/10/2016)... New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the ... vaccines and immunotherapies for infectious diseases and cancer. , The Human ...
(Date:2/10/2016)... MO (PRWEB) , ... February 10, 2016 , ... ... will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st ... ISPE is expecting to fill more than 100 tables for its annual event, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Global Stem Cells ... with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical ... the latest adipose and bone marrow therapies. , Through the new collaboration, ...
Breaking Biology Technology: